Washburn Capital Management, Inc. Johnson & Johnson Transaction History

Washburn Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	SELL	$151.05 - $180.26 $151,654 - $180,981	-1,004 Reduced 17.08%	4,873 $755,000
Q4 2022 Feb 07, 2023	BUY	$160.2 - $179.79 $200,250 - $224,737	1,250 Added 27.02%	5,877 $1.04 Million
Q3 2022 Oct 28, 2022	BUY	$161.33 - $179.52 $72,759 - $80,963	451 Added 10.8%	4,627 $756,000
Q2 2022 Jul 15, 2022	BUY	$168.19 - $186.01 $405,169 - $448,098	2,409 Added 136.33%	4,176 $741,000
Q1 2022 May 06, 2022	BUY	$158.14 - $179.59 $279,433 - $317,335	1,767 New	1,767 $313,000
Q2 2021 Aug 02, 2021	SELL	$159.48 - $171.07 $233,957 - $250,959	-1,467 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$153.07 - $170.48 $224,553 - $250,094	1,467 New	1,467 $241,000

4,227

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Washburn Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Washburn Capital Management, Inc. with notifications on news.